Search / Trial NCT06222996

VACCINE HESITATION

Launched by YUZUNCU YIL UNIVERSITY · Jan 24, 2024

Trial Information

Current as of October 04, 2024

Enrolling by invitation

Keywords

Vaccine Hesitancy Vaccine Literacy Immunization Primiparous Pediatric Nursing Web Page

Description

Vaccination, which is one of the basic elements of preventive health services, is the most effective, safe and cost-effective health practice in protecting human health and preventing infectious diseases. Vaccination has been recognized as the most effective method for people to cope with infectious diseases. Vaccines protect infants and children against many diseases. Every year, 1 million 700 thousand people die in the world due to vaccine-preventable diseases (Odabaş \& Kuzlu Ayyıldız, 2021). Despite scientific and historical evidence of the safety and effectiveness of vaccines and immu...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * Pregnancy over 18 years of age
  • * Primiparity
  • * Using social media
  • * Literacy
  • * Volunteering to participate in the study
  • Exclusion Criteria:
  • * Adolescent pregnancy (under 18 years of age)
  • * Pregnancy ended in miscarriage or foetal death
  • * Communication problems
  • * Having any psychiatric problem
  • * Having a chronic disease
  • * Multiparity
  • * Not volunteering to participate in the study

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Van, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0